《當(dāng)代分子藥理學(xué)》旨在發(fā)表細(xì)胞和分子藥理學(xué)的最新進(jìn)展，重點(diǎn)介紹正在開(kāi)發(fā)的新藥物的作用機(jī)制、創(chuàng)新藥理學(xué)技術(shù)、細(xì)胞信號(hào)、轉(zhuǎn)導(dǎo)途徑分析、基因組學(xué)、蛋白質(zhì)組學(xué)和代謝組學(xué)在藥物作用中的應(yīng)用。另一個(gè)重點(diǎn)將是如何通過(guò)了解藥物在細(xì)胞和分子水平上的作用來(lái)闡明正常的生物功能。該雜志出版有關(guān)分子藥理學(xué)的專(zhuān)家評(píng)論、原創(chuàng)研究文章和專(zhuān)題問(wèn)題。《現(xiàn)代分子藥理學(xué)》是一份重要的期刊，為每一位參與藥物設(shè)計(jì)和發(fā)現(xiàn)、目標(biāo)識(shí)別、目標(biāo)驗(yàn)證、臨床前和臨床開(kāi)發(fā)的科學(xué)家提供治療人類(lèi)疾病的有用藥物。

Current Molecular Pharmacology aims to publish the latest developments in cellular and molecular pharmacology with a major emphasis on the mechanism of action of novel drugs under development, innovative pharmacological technologies, cell signaling, transduction pathway analysis, genomics, proteomics, and metabonomics applications to drug action. An additional focus will be the way in which normal biological function is illuminated by knowledge of the action of drugs at the cellular and molecular level. The journal publishes expert reviews , original research articles and thematic issues on molecular pharmacology.Current Molecular Pharmacology is an essential journal for every scientist who is involved in drug design and discovery, target identification, target validation, preclinical and clinical development of drugs therapeutically useful in human disease.